Study Purpose: This research is exploring the safety and best dosage of an investigational medication for adults with advanced solid tumors or lymphomas. It aims to see if the medication can stop cancer cell growth by blocking certain enzymes.
Duration & Visits: Participants will take the medication by mouth for 4 days, then have 3 days off in each 28-day cycle. The study continues as long as the treatment is effective and without severe side effects. After finishing, there’s a 30-day follow-up.
Eligibility: Adults with advanced cancer that has spread and who have tried standard treatments without success. Participants need to be healthy enough to join and willing to use birth control during the study.
- Commitment: The study involves regular cycles of medication and follow-ups.
- Considerations: Participants must not have certain health issues like uncontrolled infections or recent heart problems.
- Requirements: Participants need to agree to two biopsy procedures if possible and avoid other investigational treatments.
Contact us to see if you qualify and want to participate in this study.